OOIR: Observatory of International Research

Papers

(The median citation count of Current Neuropharmacology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Neurocognitive Correlates of Cerebellar Volumetric Alterations in Youth with Pediatric Bipolar Spectrum Disorders and Bipolar Offspring	142
Mimicking Extracellular Matrix via Engineered Nanostructured Biomaterials for Neural Repair	126
Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management	105
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder	102
Childhood Trauma and Self-harm in Youths with Bipolar Disorders	90
Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease	83
Role of Glycerophospholipid Metabolism in Epilepsy	81
Redox Modulation of Meniere Disease by Coriolus versicolor Treatment, a Nutritional Mushroom Approach with Neuroprotective Potential	81
siRNA Therapeutics: Future Promise for Neurodegenerative Diseases	79
The Role of Natural Products in Treatment of Depressive Disorder	74
Early Family Intervention for Youth at Risk for Bipolar Disorder: Psychosocial and Neural Mediators of Outcome	68
Modulating Ferroptosis: A Novel Approach to Promote Neural Repair in Brain Injury	63
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study	62
Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction	62
Local and Remote Chemogenetic Suppression of Hippocampal Seizures in Rats	58
Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS	54
Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinson’s Disease: An Update Since 2017	50
Thematic Selection: Stress and Stress-related Disorders Neurobiology & Translational Aspects of Stress-related Disorders (Part 3)	49
The Effects of Drugs used for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Pregnancy Outcome and Breast-feeding: A Critical Review	49
Perspective on the Relationship between GABAA Receptor Activity and the Apparent Potency of an Inhibitor	47
Unraveling the Role of Perivascular Macrophages in Alzheimer's Disease: Insights from the Crosstalk between Immunometabolism and Ferroptosis	47
Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis	47
Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase	47
Meet the Editorial Board Member	47
Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials	46

Exploring Mechanistic Insights by Carotenoids in Neuropathic and Inflammatory Pain	46
Myeloid-derived Suppressor Cells and Multiple Sclerosis	45
The Formyl Peptide Receptor 2 as a Target for Promotion of Resolution of Inflammation	42
Unveiling the Potential Neuroprotective Effect of Bioactive Compounds from Plants with Sedative and Mood-Modulating Properties: Innovative Approaches for the Prevention of Alzheimer's and Parkinson's	41
Microglia-Astrocyte Crosstalk in Post-Stroke Neuroinflammation: Mechanisms and Therapeutic Strategies	40
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy	40
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study	40
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics	40
OL-FS13 Alleviates Cerebral Ischemia-reperfusion Injury by Inhibiting miR-21-3p Expression	40
Antiseizure Medications: Advancements, Challenges, and Prospects in Drug Development	39
The Mechanisms and Application Prospects of Astrocyte Reprogramming into Neurons in Central Nervous System Diseases	37
Antioxidants, Hormetic Nutrition, and Autism	37
What is the Role of Lithium in Epilepsy?	37
Role of Traditional Chinese Medicine Formulations in Reducing Neuroinflammation and Oxidative Stress in Alzheimer’s Disease	37
Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment	35
Role of Microglia in Psychostimulant Addiction	34
Meet the Country Editor	34
Fast Declining Prediction in Alzheimer’s Disease from Early Clinical Assessment	34
mGlu3 Metabotropic Glutamate Receptors as a Target for the Treatment of Absence Epilepsy: Preclinical and Human Genetics Data	34
Corrigendum to: “Effects of Alcohol on EEG Activity: A Systematic Review Focused on Sex-Related Differences in Youth”	34
Diabetes, Alzheimer's Disease Risk Factors, and the Cafeteria Diet: A Comprehensive Review	33
The Emerging Role of Quercetin in the Treatment of Chronic Pain	33
Resveratrol Supplementation Modulates Endothelial Dysfunction in Alzheimer’s Disease (AD): In Vitro Effects on Human Aortic Endothelial Cells Exposed to AD Plasma	33
Meet the Editorial Board Member	32
Major Depression in Comorbidity with Substance use Disorders: Patients’ Features and Clinical-Neurobiological Rationale of Antidepressant Treatments	32
Early Enteral Feeding Restores Neurofilament Light Chain Serum Levels in Preterm Newborns	31
New Insights of Early Brain Injury after Subarachnoid Hemorrhage: A Focus on the Caspase Family	31
Is Antipsychotic Drug Use During Pregnancy Associated with Increased Malformation Rates and Worsening of Maternal and Infant Outcomes? A Systematic Review	30
Gut Microbiome in Alzheimer’s Disease: from Mice to Humans	30
Vortioxetine versus SSRI/SNRI with Pregabalin Augmentation in Treatment-Resistant Burning Mouth Syndrome: A Prospective Clinical Trial	30
Functional and Clinical Relevance of the Crosstalk between the Glymphatic System and the Lymphatic System	30
The Role of the Microbiota-Gut-Brain Axis in Perinatal Depression: Novel Insights for Treatment	29
Daridorexant and Insomnia in Clinical Practice: A Nominal GroupTechnique Consensus Study among Italian Sleep and Insomnia Experts	29
The Lymphatic System In The Brain Clearance Mechanisms - New Therapeutic Perspectives For Alzheimer's Disease	28
How to Optimize the Effectiveness and Safety of Parkinson’s Disease Therapy? – A Systematic Review of Drugs Interactions with Food and Dietary Supplements	28
Long-term Efficacy and Safety of Sodium Oxybate in Treating Alcohol Use Disorder: A Systematic Review and Meta-Analysis	28
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease	27
Meet the Editorial Board Member	27
Paraquat and Parkinson’s Disease: The Molecular Crosstalk of Upstream Signal Transduction Pathways Leading to Apoptosis	27
Pathomechanistic Networks of Motor System Injury in Amyotrophic Lateral Sclerosis	26
The Role of Epigenetics in the Pathogenesis and Potential Treatment of Attention Deficit Hyperactivity Disorder	26
In Vitro and In Vivo Evaluation of Kai-Xin-San Polysaccharides: Antioxidant, Anti-Inflammatory, and Anti-Alzheimer's Disease Activities	25
Neuroinflammation: The Role of Anthocyanins as Neuroprotectants	25
Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds	25
Toxic Effects of Methamphetamine on Perivascular Health: Co-morbid Effects of Stress and Alcohol Use Disorders	25
Alzheimer's Disease May Benefit from Olive Oil Polyphenols: A Systematic Review on Preclinical Evidence Supporting the Effect of Oleocanthal on Amyloid-β Load	25
A Review on Preclinical Models of Ischemic Stroke: Insights Into the Pathomechanisms and New Treatment Strategies	25
Aryl Hydrocarbon Receptor Establishes a Delicate Balance between the Level of the Trace Amine Tryptamine and Monoamine Oxidase Activity in the Brain and Periphery in Health and Conditions such as Neur	25
Depression: An Insight into Heterocyclic and Cyclic Hydrocarbon Compounds Inspired from Natural Sources	24
Hydroxychloroquine Prevents High-altitude Cerebral Edema by Inhibiting Endothelial Claudin-5 Autophagic Degradation	24

New Insights on Mechanisms and Therapeutic Targets of Cerebral Edema	24
Serine Proteases and Chemokines in Neurotrauma: New Targets for Immune Modulating Therapeutics in Spinal Cord Injury	24
The Role of Induced Pluripotent Stem Cells in the Treatment of Stroke	24
Effects of Natural Products on Neuromuscular Junction	23
Spatiomolecular Characterization of Dopamine D2 Receptors Cells in the Mouse External Globus Pallidus	23
Dapsone, More than an Effective Neuro and Cytoprotective Drug	23
From Phenomes to Genes: Phenotype-based Strategies in Rodents for Research on the Neurobiological and Genetic Bases of Psychiatric-relevant Traits	23
Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological Disorders	23
Depression and the Glutamate/GABA-Glutamine Cycle	23
Sensory Reinforced Corticostriatal Plasticity	23
Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer’s Disease: Recent Advances and Therapeutic Implications	23
Meet the Section Editor	22
Association between Suicidal Ideation and Immune Parameters in First-episode Patients with Schizophrenia	22
Emerging Roles of Microglia in Blood-Brain Barrier Integrity in Aging and Neurodegeneration	22
Prospective Investigation of Glutamate Levels and Percentage Gray Matter in the Medial Prefrontal Cortex in Females at Risk for Postpartum Depression	22
Bibliometric Analysis of Antipsychotic-induced Metabolic Disorder from 2006 to 2021 Based on WoSCC Database	22
Advances in the Therapeutic Use of Non-Ergot Dopamine Agonists in the Treatment of Motor and Non-Motor Symptoms of Parkinson’s Disease	22
Bibliometric Analysis of the Research Status and Global Trends in Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease from 2002 to 2022	21
The Potential Role of Glutamate Receptors and their Antagonists or Modulators in Migraine Therapy	21
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis	21
Neonatal Arterial Ischaemic Stroke: Advances in Pathologic Neural Death, Diagnosis, Treatment, and Prognosis	21
Machine Learning and Pharmacogenomics at the Time of Precision Psychiatry	21
Targeting Estrogen Signaling in the Radiation-induced Neurodegeneration: A Possible Role of Phytoestrogens	21
The Dual Role of Microglia in Multiple Sclerosis and its Implications for Diagnostics and Repair	21
Current Insights into the Neurotoxicity of Melamine: A Comprehensive Review	20
Lurasidone vs. Other Antipsychotics as Augmentation Strategies for Clozapine in Treatment-resistant Schizophrenia: An Observational Multicenter Prospective Study	20
Advances in the Mechanism of ceRNA Regulation in Postoperative Cognitive Dysfunction	20
The Role of Caspase Family in Acute Brain Injury: The Potential Therapeutic Targets in the Future	20
The Modulatory Effects of Anesthetics and Analgesics onNeurophysiological Monitoring and Underlying Mechanisms	20
Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-scale Randomized Controlled Trial	20
Virtual Screening-Based Drug Development for the Treatment of Nervous System Diseases	19
Sensorimotor Alterations Induced by Novel Fentanyl Analogs in Mice: Possible Impact on Human Driving Performances	19
Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions	19
A New Augmentation Strategy against Depression Combining SSRIs and the N-terminal Fragment of Galanin (1-15)	19
Biomaterials for Neurotherapeutics: From Lab Discovery to Clinical Application	19
Titration of Pharmacological Responses in ICU Patients by Quantified EEG	19
Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis	19
The Potential Influence of Associated Antidepressants on the Pharmacokinetic Profile of Esketamine in Patients Affected by Treatment-resistant Depression	19
The Comprehensive Neural Mechanism of Oxytocin in Analgesia	19
Structural and Functional MRI Brain Changes in Patients with Schizophrenia Following Electroconvulsive Therapy: A Systematic Review	19
Post-Herpetic Neuralgia: Review of Pathophysiology, Mechanisms, and Drug Treatment	19
Meet the Editorial Board Member	19
Targeting the Main Sources of Reactive Oxygen Species Production: Possible Therapeutic Implications in Chronic Pain	18
Fabry Disease: Current and Novel Therapeutic Strategies. A Narrative Review	18
Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease	18
Modulation of in vitro Network Activity by Optogenetic Stimulation of Parvalbumin-positive Interneurons During Estrous Cycle	18
Advances on Epigenetic Drugs for Pediatric Brain Tumors	18
Interleukin-17A in Alzheimer’s Disease: Recent Advances and Controversies	18
The Dorsolateral Prefrontal Cortex: A High-level Hub for Allostatic Cardiovascular Control	18
The Diverse Network of Brain Histamine in Feeding: Dissect its Functions in a Circuit-Specific Way	18
Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer’s Disease	18
Development of Non-opioid Analgesics Targeting Two-pore Domain Potassium Channels	17
Cholesterol in Brain Development and Perinatal Brain Injury: More than a Building Block	17
UFMylation: A Potential Modification for Neurological Diseases	17
Isolated Mitochondrial Preparations andIn organelloAssays: A Powerful and RelevantEx vivoTool for Assessment of Brain (Patho)physiology	17
Resilience and Recalibration of Bibliometric Indicators in Neurosciencesand Neuropharmacology Journals After COVID-19: A Longitudinal Rateof Change Analysis Using Mixed-Effects Models	17
Secondary White Matter Injury Mediated by Neuroinflammation after Intracerebral Hemorrhage and Promising Therapeutic Strategies of Targeting the NLRP3 Inflammasome	17
The Role of Total White Blood Cell Count in Antipsychotic Treatment for Patients with Schizophrenia	17
An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson’s Disease	17
Intercellular Communication Pathways in Cerebral Ischemia:Mechanisms, Molecular Insights, and Therapeutic Implications	17
Early-Life Microbiome and Neurodevelopmental Disorders: A Systematic Review and Meta-Analysis	17
Association of Oxidative Stress with Neurological Disorders	17
Cariprazine Augmentation in Treatment-Resistant Bipolar Depression: Data from a Retrospective Observational Study	17
Restoring Brain Pathways Involved in Diabetes-Associated Neurocognitive Disorders: The Potential of Dipeptidyl Peptidase 4 Inhibitors as a Therapeutic Strategy	16
Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels	16
Acknowledgements to Reviewers	16
Does the Brain Matter? Cortical Alterations in Pediatric Bipolar Disorder: A Critical Review of Structural and Functional Magnetic Resonance Studies	16
7,8-Dihydroxyflavone and Neuropsychiatric Disorders: A Translational Perspective from the Mechanism to Drug Development	16
Contributions of Zebrafish Studies to the Behavioural Consequences of Early Alcohol Exposure: A Systematic Review	16
Abusive use of Zolpidem as a Result of COVID-19 and Perspectives of Continuity of the Problem in the Post-Pandemic Period	15
Central Sensitization and Pain: Pathophysiologic and Clinical Insights	15
Pathways from the Superior Colliculus to the Basal Ganglia	15
Epigenetics of Fear, Anxiety and Stress – Focus on Histone Modifications	15
Therapeutic Approaches Interfering with Nuclear Localization Signals: An Emerging Strategy for CNS-Related Diseases	15
Determining the Interaction in a Drug Combination using the Dose-based or Effect-based Method	15
How to Modulate Peripheral and Central Nervous System to Treat Acute Postoperative Pain and Prevent Pain Persistence	15
Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression	15
Vasoactive Intestinal Peptide: A Neuropeptide that Plays an ImportantRole in Parkinson's Disease	15
Mediterranean Pattern Diet in Multiple Sclerosis: A Review Focusing on Immunometabolites	15
Exploring the Effectiveness and Potential Pharmacological Mechanism of Minocycline for Spinal Cord Injury through Meta-Analysis and Network Pharmacology	15

Beyond its Psychiatric Use: The Benefits of Low-dose Lithium Supplementation	15
A Bibliometric and Visual Analysis of Single Nucleotide Polymorphism Studies in Depression	15
Natural Products-based Drugs: Potential Drug Targets Against Neurological Degeneration	15
The Fragile Balance: Autophagy's Role in Neurodegenerative DiseaseProgression	15
Galectin-3 in Microglia-Mediated Neuroinflammation: Implications for Central Nervous System Diseases	15
Preface	14
Meet the Section Editor	14
A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis	14
Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder	14
Emerging Neurobiological Concepts and Therapies for Neurological Rare Diseases	14
Antidepressant Prescription for Major Depressive Disorder: Results from a Population-Based Study in Italy	14
Immune System and Methamphetamine: Molecular Basis of a Relationship	14
Bipolar Disorder and Manic-Like Symptoms in Alzheimer’s, Vascular and Frontotemporal Dementia: A Systematic Review	14
Contribution of Drugs to Drowning in Scotland from 1996 to 2020	14
MicroRNAs as Potential Biomarkers and Therapeutic Targets in Ischemic Stroke from the Perspective of Inflammation	14
Meet the Country Editor	14
Potential Benefits of Quercetin through P2X7 Modulation against Neuroinflammation in Alzheimer's Disease	14
Epigenetic Mechanisms in the Pathophysiology and Progression of Epilepsy: A Comprehensive Review of Experimental and Clinical Studies	14
Differing Prevalence and Correlates of Metabolic Syndromes Between Chlorpromazine and Clozapine: A 10-year Retrospective Study of a Male Chinese Cohort	14
Striatal Acetylcholine and Dopamine Interactions Produce Situationappropriate Action Selection	14
Protein Kinases in Alzheimer’s Disease: Pioneering Insights into Pathogenesis and Therapeutic Breakthroughs	13
Neutrophil Heterogeneity and its Roles in the Inflammatory Network after Ischemic Stroke	13
Powering Up the Brain: Intercellular Mitochondrial Quality Control andIts Implication in Stroke	13
Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint	13
Rethinking ‘Innovation’ in Psychiatry with Older and Newer Treatments: From Bench to Benchside	13
Two Distinct Neuronal Populations in the Rat Parafascicular Nucleus Oppositely Encode the Engagement in Stimulus-driven Reward-seeking	13
Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review	13
Neurobehavioral Profiles of Six Genetically-based Rat Models of Schizophrenia- related Symptoms	13
The Natural Protoalkaloid Methyl-2-Amino-3-Methoxybenzoate (MAM) Alleviates Positive as well as Cognitive Symptoms in Rat and Mouse Schizophrenia Models	13
Clinical Trials of Non-Coding RNAs as Diagnostic and Therapeutic Biomarkers for Central Nervous System Injuries	13
Therapeutic Potential of Anesthesiology for Sleep Disorders in the Perioperative Period	13
Glucocorticosteroids Effects on Brain Development in the Preterm Infant: A Role for Microglia?	13
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study)	13
Epilepsy and Cognitive Impairment in Childhood and Adolescence: A Mini-Review	13
Symptoms of Protracted Alcohol Withdrawal in Patients with Alcohol Use Disorder: A Comprehensive Systematic Review	13
Promising Perspective to Facioscapulohumeral Muscular Dystrophy Treatment: Nutraceuticals and Phytochemicals	12
Anticholinesterases Traits Inbuilt in Buxaceae Plant Extracts against Alzheimer’s Disease	12
The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review	12
Progress in Neuropharmacology of Anesthetics and Analgesics for the Improvement of Medical Treatment	12
Meet the Co-Editor	12
Viruses Broaden the Definition of Life by Genomic Incorporation of Artificial Intelligence and Machine Learning Processes	12
The Use of Zebrafish as a Non-traditional Model Organism in Translational Pain Research: The Knowns and the Unknowns	12
Microtubule-modulating Agents in the Fight Against Neurodegeneration: Will it ever Work?	12
The Orexin System: A Potential Player in the Pathophysiology of Absence Epilepsy	12
Olanzapine-Induced Weight Gain and Glycolipid Metabolism Aberrations in First-Episode and Antipsychotic-Naïve Schizophrenia Patients: A Longitudinal Study	12
Meet the Co-Editor	12
Traditional and Innovative Anti-seizure Medications Targeting Key Physiopathological Mechanisms: Focus on Neurodevelopment and Neurodegeneration	12
Extracellular Vesicles, Stem Cells and the Role of miRNAs in Neurodegeneration	12
Effects of Alcohol on EEG Activity: A Systematic Review Focused on Sex-Related Differences in Youth	12
Epilepsy and Related Neuropsychiatric Comorbidities: Basic and Clinical Research	12
The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease	12
Protective Role of Electroacupuncture Against Cognitive Impairment in Neurological Diseases	12
Dietary Intervention with Omega-3 Fatty Acids Mitigates Maternal High-Fat Diet-Induced Behavioral and Myelin-Related Alterations in Adult Offspring	12
Neuropathic Pain in Aged People: An Unresolved Issue Open to Novel Drug Approaches, Focusing on Painful Diabetic Neuropathy	12
K_Ca-Related Neurological Disorders: Phenotypic Spectrum and Therapeutic Indications	11
The Involvement of Kynurenine Pathway in Neurodegenerative Diseases	11
Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases	11
Epilepsy in Cerebrovascular Diseases: A Narrative Review	11
Comparison of the Antianhedonic Effects of Repeated-dose Intravenous Ketamine in Older and Younger Adults with Major Depressive Episode	11
Overcoming the Challenges of Detecting GPCR Oligomerization in the Brain	11
A Novel Network Pharmacology Strategy for Retrieving a Key Functional Component Group and Mechanisms in the Di-Huang-Yin-Zi Treatment of Parkinson's Disease	11
Identifying c-fos Expression as a Strategy to Investigate the Actions of General Anesthetics on the Central Nervous System	11
Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review	11
Quercetin Protects against Ethanol-induced Neurodegeneration in Adult Rat Cortex	11
Notch Signaling in Central Nervous System: From Cellular Development to Multiple Sclerosis Disease	11
The Role of circRNAs in the Pathological Mechanisms of Alzheimer's Disease: Potential Biomarkers for Diagnosis	11
mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases	11
Microglia-Neuron Interactions in Alzheimer's Disease	11
From a Cycle to a Period: The Potential Role of BDNF as Plasticity and Phase-Specific Biomarker in Cocaine Use Disorder	10
Meet the Section Editor	10
Affective and Cognitive Impairments in Rodent Models of Diabetes	10
Therapeutic Integrity of Microbiome-based Medicines in Neurodegenerative Disorders	10
Knowledge and Use of Over-the-counter Drugs in Italy: An Exploratory Survey-based Study in the General Population	10
Age-Dependent Correlation between Immune Parameters and Symptoms in Young Adults with Schizophrenia	10
Recent Investigations on the Functional Role of Cerebellar Neural Networks in Motor Functions & Nonmotor Functions -Neurodegeneration	10
The Biological Changes of Synaptic Plasticity in the Pathological Process of Sepsis-associated Encephalopathy	10
Meet the Country Editor	10
Mendelian Randomization Uncovers Potential Repurposable Medications for Neuropsychiatric Disorders	10
Smoking Affects the Predictive Roles of Antioxidant Enzymes in the Clinical Response to Risperidone in Schizophrenia: A Large-scale Cohort Study	10
Lysosomal Channels as New Molecular Targets in the Pharmacological Therapy of Neurodegenerative Diseases via Autophagy Regulation	10
Ms. Rabia Moin: A Linchpin in the Road to Success of Current Neuropharmacology	10
Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer’s Disease: Current Evidence and Future Avenues	10
Venlafaxine and Delirium: Understanding the Association.	10
Impact of Stress on Brain Morphology: Insights into Structural Biomarkers of Stress-related Disorders	10
Fluvoxamine and Amantadine: Central Nervous System Acting Drugs Repositioned for COVID-19 as Early Intervention	10
Modulating Mitochondrial Dynamics Mitigates Cognitive Impairment in Rats with Myocardial Infarction	9
The Astrogenic Balance in the Aging Brain	9
Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications	9
Reconfigurations of Dynamic Functional Network Connectivity in Large-scale Brain Network after Prolonged Abstinence in Heroin Users	9
Biphasic Hormetic-like Effect of Lebecetin, a C-type Lectin of Snake Venom, on Formalin-induced Inflammation in Mice	9
Metabolic Reprogramming in Gliocyte Post-cerebral Ischemia/ Reperfusion: From Pathophysiology to Therapeutic Potential	9
Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders	9
Serum MicroRNAs as Predictors of Diagnosis and Drug-resistance in Temporal Lobe Epilepsy: A Preliminary Study	9
Peripheral Nervous System Pain Modulation	9
Interaction between Zinc, GPR39, BDNF and Neuropeptides in Depression	9